Compare Stocks: HIMS, DGX, GH, and BTSG

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTSG BrightSpring Health Services	$62.56 +3.0%	$64.94	$25.06 ▼ $73.75	$12.38B	1.84	2.95 million shs	3.21 million shs
DGX Quest Diagnostics	$235.78 -0.6%	$228.13	$171.18 ▼ $247.19	$26.02B	0.55	953,249 shs	728,929 shs
GH Guardant Health	$160.98 -0.3%	$160.05	$53.40 ▼ $176.58	$21.60B	1.57	2.28 million shs	2.04 million shs
HIMS Hims & Hers Health	$28.09 +1.4%	$31.55	$13.74 ▼ $65.30	$6.55B	2.42	25.13 million shs	8.54 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTSG BrightSpring Health Services	0.00%	+3.99%	-2.72%	-0.44%	+151.68%
DGX Quest Diagnostics	0.00%	-1.75%	-0.49%	+15.69%	+29.06%
GH Guardant Health	0.00%	+1.50%	-4.20%	+24.05%	+168.44%
HIMS Hims & Hers Health	0.00%	-6.43%	-12.41%	-4.67%	-42.84%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTSG BrightSpring Health Services	$62.56 +3.0%	$64.94	$25.06 ▼ $73.75	$12.38B	1.84	2.95 million shs	3.21 million shs
DGX Quest Diagnostics	$235.78 -0.6%	$228.13	$171.18 ▼ $247.19	$26.02B	0.55	953,249 shs	728,929 shs
GH Guardant Health	$160.98 -0.3%	$160.05	$53.40 ▼ $176.58	$21.60B	1.57	2.28 million shs	2.04 million shs
HIMS Hims & Hers Health	$28.09 +1.4%	$31.55	$13.74 ▼ $65.30	$6.55B	2.42	25.13 million shs	8.54 million shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTSG BrightSpring Health Services	0.00%	+3.99%	-2.72%	-0.44%	+151.68%
DGX Quest Diagnostics	0.00%	-1.75%	-0.49%	+15.69%	+29.06%
GH Guardant Health	0.00%	+1.50%	-4.20%	+24.05%	+168.44%
HIMS Hims & Hers Health	0.00%	-6.43%	-12.41%	-4.67%	-42.84%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTSG BrightSpring Health Services	3.10	Buy	$70.71	13.02% Upside
DGX Quest Diagnostics	2.54	Moderate Buy	$236.31	0.23% Upside
GH Guardant Health	2.96	Moderate Buy	$184.58	14.66% Upside
HIMS Hims & Hers Health	2.19	Hold	$32.50	15.70% Upside

Current Analyst Ratings Breakdown

Latest HIMS, DGX, GH, and BTSG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/8/2026	DGX Quest Diagnostics	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$232.00 ➝ $245.00
9/8/2026	GH Guardant Health	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$203.00
9/2/2026	GH Guardant Health	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$195.00
8/25/2026	GH Guardant Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/24/2026	HIMS Hims & Hers Health	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$27.00 ➝ $32.00
8/21/2026	HIMS Hims & Hers Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$39.00 ➝ $35.00
8/13/2026	BTSG BrightSpring Health Services	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$90.00
8/12/2026	DGX Quest Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B+) ➝ Buy (A-)
8/11/2026	HIMS Hims & Hers Health	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $26.00
8/11/2026	HIMS Hims & Hers Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $30.00
8/11/2026	HIMS Hims & Hers Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$21.00 ➝ $28.00

(Data available from 9/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTSG BrightSpring Health Services	$12.91B	0.96	$2.26 per share	27.64	$10.40 per share	6.02
DGX Quest Diagnostics	$11.04B	2.36	$15.08 per share	15.63	$64.78 per share	3.64
GH Guardant Health	$982.02M	22.00	N/A	N/A	($0.79) per share	-203.77
HIMS Hims & Hers Health	$2.35B	2.79	$0.85 per share	33.11	$2.38 per share	11.80

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTSG BrightSpring Health Services	$190.67M	$1.66	37.69	27.68	0.71	2.55%	16.73%	5.24%	10/19/2026 (Estimated)
DGX Quest Diagnostics	$992M	$9.42	25.03	19.70	2.17	9.18%	16.01%	7.27%	10/20/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	10/28/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	56.18	N/A	-5.51%	-6.51%	-1.20%	11/9/2026 (Estimated)

Latest HIMS, DGX, GH, and BTSG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million
7/31/2026	Q2 2026	BTSG BrightSpring Health Services	$0.3963	$0.45	+$0.0537	$0.38	$3.66 billion	$3.87 billion
7/30/2026	Q2 2026	GH Guardant Health	-$0.7618	-$0.42	+$0.3418	-$0.90	$314.23 million	$334.98 million
7/23/2026	Q2 2026	DGX Quest Diagnostics	$2.82	$3.12	+$0.30	$2.84	$2.97 billion	$3.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTSG BrightSpring Health Services	N/A	N/A	N/A	N/A	N/A
DGX Quest Diagnostics	$3.44	1.46%	+7.34%	36.52%	14 Years
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A

Latest HIMS, DGX, GH, and BTSG Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	DGX Quest Diagnostics	quarterly	$0.86	1.45%	10/6/2026	10/6/2026	10/21/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTSG BrightSpring Health Services	1.06	1.59	1.22
DGX Quest Diagnostics	0.72	1.59	1.46
GH Guardant Health	N/A	4.03	3.71
HIMS Hims & Hers Health	4.21	0.93	0.87

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BTSG BrightSpring Health Services	N/A
DGX Quest Diagnostics	88.06%
GH Guardant Health	92.60%
HIMS Hims & Hers Health	63.52%

Insider Ownership

Company	Insider Ownership
BTSG BrightSpring Health Services	2.80%
DGX Quest Diagnostics	0.88%
GH Guardant Health	5.60%
HIMS Hims & Hers Health	11.76%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BTSG BrightSpring Health Services	23,500	197.86 million	192.32 million	Optionable
DGX Quest Diagnostics	57,000	110.37 million	109.40 million	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Not Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable

HIMS, DGX, GH, and BTSG Headlines

Recent News About These Companies

Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (HIMS) with Significant Losses to a Securities Class Action Deadline on November 2, 2026

2 hours ago | newsfilecorp.comN

HIMS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

September 8 at 1:12 PM | newsfilecorp.comN

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

September 8 at 12:00 PM | newsfilecorp.comN

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law

September 8 at 10:29 AM | globenewswire.com

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

September 8 at 10:01 AM | zacks.com

HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline

September 8 at 9:28 AM | globenewswire.com

Hims & Hers Health, Inc. $HIMS Stock Position Trimmed by Wellington Management Group LLP

September 8 at 5:03 AM | marketbeat.com

Hims & Hers Health, Inc. (HIMS) Securities Fraud Class Action Lawsuit Filed; November 2, 2026, Lead Plaintiff Deadline

September 7 at 5:57 PM | financialcontent.comF

Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

September 7 at 1:50 PM | prnewswire.com

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

September 7 at 12:00 PM | globenewswire.com

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

September 6 at 12:00 PM | prnewswire.com

HIMS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

September 6 at 9:24 AM | newsfilecorp.comN

INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

September 5 at 10:40 AM | prnewswire.com

Hims & Hers Health, Inc. $HIMS Shares Bought by FirstWave Capital Management LLC

September 5 at 4:15 AM | marketbeat.com

B. Metzler seel. Sohn & Co. AG Purchases New Holdings in Hims & Hers Health, Inc. $HIMS

September 5 at 3:07 AM | marketbeat.com

Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026

September 4, 2026 | theglobeandmail.com

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

September 4, 2026 | prnewswire.com

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit ...

September 4, 2026 | gazettextra.comG

Kaplan Fox Reminds Hims & Hers Health, Inc. (HIMS) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 2, 2026

September 4, 2026 | newsfilecorp.comN

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS

September 4, 2026 | globenewswire.com

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) Who Suffered Losses to Contact the Firm Before November 2, 2026

September 4, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, DGX, GH, and BTSG Company Descriptions

BrightSpring Health Services NASDAQ:BTSG

$62.56 +1.83 (+3.01%)

Closing price 04:00 PM Eastern

Extended Trading

$62.78 +0.22 (+0.35%)

As of 06:07 PM Eastern

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Quest Diagnostics NYSE:DGX

$235.78 -1.37 (-0.58%)

Closing price 03:59 PM Eastern

Extended Trading

$239.80 +4.03 (+1.71%)

As of 05:39 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health NASDAQ:GH

$160.98 -0.43 (-0.27%)

Closing price 04:00 PM Eastern

Extended Trading

$161.92 +0.94 (+0.59%)

As of 06:27 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health NYSE:HIMS

$28.09 +0.38 (+1.37%)

Closing price 03:59 PM Eastern

Extended Trading

$28.10 +0.00 (+0.01%)

As of 06:28 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, DGX, GH, and BTSG Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, DGX, GH, and BTSG Earnings

Compare Dividends

Latest HIMS, DGX, GH, and BTSG Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, DGX, GH, and BTSG Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, DGX, GH, and BTSG Company Descriptions

BrightSpring Health Services NASDAQ:BTSG

Quest Diagnostics NYSE:DGX

Guardant Health NASDAQ:GH

Hims & Hers Health NYSE:HIMS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools